Sonic Healthcare (ASX:SHL) added a modest +0.33% today to close at $21.48, trading between $21.25 and $21.57. The small gain comes against a one-year return of -21.23% — a meaningful decline for the pathology and diagnostic services provider, reflecting a period of pressure on testing volumes and reimbursement rates across its major international markets.

Company Overview

Sonic Healthcare provides pathology and diagnostic imaging services, operating laboratories and imaging centres across Australia, the United States, Germany, Switzerland, the United Kingdom and other international markets, serving patients and referring physicians with a broad range of diagnostic testing…